Lymphocyte-Activation Gene 3 (LAG3) Peptide
Quick Overview for Lymphocyte-Activation Gene 3 (LAG3) Peptide (ABIN938646)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LAG3 antibody,
Alternative Names: LAG3 control peptide, LAG3 antibody Blocking Peptide, Anti-LAG3 Blocking Peptide, lymphocyte-activation gene 3 Blocking Peptide, CD223 Blocking Peptide, LAG3, LAG-3, LAG 3, LAG-3 Blocking Peptide, LAG 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Background
- Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
-
Molecular Weight
- 55 kDa
Target
-